The global Blood-Based Biomarker market is estimated to be valued at US$ 18,803.3 million in 2022 and is expected to exhibit a CAGR of 12.8% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Blood-based biomarkers are measurable substances or indicators found in blood that are used to identify or predict various diseases or conditions. These biomarkers play a crucial role in early disease detection, ... Read more
